Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease.
Serial extraction study of Alzheimer's disease (AD) and control brains revealed 4, 3.7 and 3 kD amyloid beta protein (A beta) species accumulated in AD brains. In the fractions extracted with TBS, 10% SDS and formic acid, considerable amounts of A beta species were recovered in SDS fractions besides TBS and formic acid fractions. Immunoblotting with several site-specific antibodies confirmed not only the presence of 4 kD A beta starting at the first amino acid of A beta but also 2 smaller A beta species with modification of their amino-termini in the highly resolutional Tris/Tricine gel system. A beta solubility using these solvents was associated with both modification of the amino-terminus and length of carboxyl-terminus of A beta. Especially, a large amount of modified A beta was found to be accumulated as forms with different solubility in AD brains.
Harigaya
Y
Y
Department of Neurology, Gunma University School of Medicine, Japan.
Shoji
M
M
Kawarabayashi
T
T
Kanai
M
M
Nakamura
T
T
Iizuka
T
T
Igeta
Y
Y
Saido
T C
TC
Sahara
N
N
Mori
H
H
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease; D016229:Amyloid beta-Peptides / Q000737:chemistry* / Q000276:immunology; D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D001923:Brain Chemistry; D015200:Fluoroimmunoassay; D006801:Humans; D015151:Immunoblotting
D016229:Amyloid beta-Peptides; D000911:Antibodies, Monoclonal